Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06760377

Dietary Supplements for Reduction of Intestinal Permeability Levels

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
85 (estimated)
Sponsor
Universidad Complutense de Madrid · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A randomised and controlled trial, in which the effect of a dietary supplement is evaluated for reduction of intestinal permeability levels of subjects with high levels of zonulin in feces

Detailed description

Randomized clinical trial, with masking of the statistician and the evaluator, to assess the effect of a food supplement, composed of substances that promote intestinal mucosa repair, on the levels of zonulin in feces and consequently on intestinal permeability. A control group of subjects not receiving any type of supplementation will be used to compare the effectiveness of the treatment. The main objective of this study is to determine if the use of a dietary supplement composed of glutamine, butyrate and lion's mane, among others, corrects the levels of zonulin in feces.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary supplement GroupSubjects belonging to the experimental group will be provided with the PermeaIntest supplement, which they will take for 60 days, 1 sachet in the morning and 1 sachet in the evening in half a glass of water. Subjects will have a stool sample collected before and after ingestion of the dietary supplement.

Timeline

Start date
2025-02-01
Primary completion
2025-04-01
Completion
2025-06-01
First posted
2025-01-06
Last updated
2025-01-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06760377. Inclusion in this directory is not an endorsement.